Much is being invested in the establishment of CLIN-Net and LAB-Net. Wouldn’t it be a shame if European society ceases to benefit from this after 2021? The answer is obvious. This story is about looking at the future and a fruitful cooperation. Prof. Dr. Marc Bonten (Scientific Coordinator COMBACTE) and Prof. Herman Goossens (Academic Lead COMBACTE-NET and LAB-Net, and Coordinator for PREPARE) share their views on the future existence of an active European network for clinical trials in infectious diseases: ECRAID.ECRAID Piece
New developments in COVID-19 consortium RECOVER
Base of our Sustainable Future
The next step in COMBACTE’s sustainable clinical research network has been taken. On June 4th the proposal for the European Clinical Research Al...